Cuenca R E, Takita H, Bankert R
Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Surg Oncol. 1996 Apr;5(2):85-91. doi: 10.1016/s0960-7404(96)80005-3.
This study presents a new technique for the orthotopic engraftment of human lung tumours in SCID mice and demonstrates the importance of a more clinically relevant route of tumour propagation for the study of metastatic potential. The orthotopic engraftment of human lung tumour biopsy specimens was performed via an anterior thoracotomy into SCID mice. Engraftment of non-small cell lung cancer specimens from nine patients into 52 SCID mice yielded a 31% engraftment rate and a 50% metastasis rate. Unlike subcutaneous inoculation, the engraftment rates following the orthotopic inoculation did not vary between squamous cell carcinomas and adenocarcinomas. Direct visceral pleural invasion was seen in most cases. Orthotopically placed tumours grew 5-fold by 4 to 6 months. Unique to this model was the observation of metastasis to clinically relevant sites, such as the adrenal gland and supraclavicular lymph nodes. Contralateral lung metastases were also noted in 37.5%, and one ovarian metastasis occurred. The procedure was well tolerated, with survival rates of 98%.
本研究提出了一种在SCID小鼠体内原位植入人肺肿瘤的新技术,并证明了对于转移潜能研究而言,采用更具临床相关性的肿瘤传播途径的重要性。通过开胸手术经前胸壁将人肺肿瘤活检标本原位植入SCID小鼠体内。将9例患者的非小细胞肺癌标本植入52只SCID小鼠,植入率为31%,转移率为50%。与皮下接种不同,原位接种后的植入率在鳞状细胞癌和腺癌之间没有差异。大多数病例可见直接侵犯脏层胸膜。原位植入的肿瘤在4至6个月内增长了5倍。该模型的独特之处在于观察到肿瘤转移至肾上腺和锁骨上淋巴结等临床相关部位。对侧肺转移率也为37.5%,还出现了1例卵巢转移。该操作耐受性良好,生存率为98%。